School of Medicine
Suresh C. Tyagi, Ph.D., studies the genetic, molecular and cellular mechanisms that contribute to hypertension diabetes and heart failure. In particular, he studies homocysteine, and amino acid by-product that plays a critical role in artery damage and may be responsible for many heart attacks in individuals who do not display traditional cardiac risk factors. His work may lead to new treatments for these conditions, which afflict millions.
Tyagi is a professor in the Department of Physiology and Biophysics in the School of Medicine. His research is supported by the National Institutes of Health. He is the recipient of numerous awards and honors including a medal of merit from the International Society for Heart Research.
Tyagi has published more than 156 peer-reviewed articles, invited papers, and reviews. He is currently principal investigator on four NIH grants totaling $6.2 million.
He has served on editorial boards and committees for the American Journal of Physiology, Clinical & Experimental Hypertension, Molecular Cellular Biochemistry and the Journal of Molecular and Cellular Physiology. He has also been a member of multiple study sections with the American Heart Association and the National Institutes of Health.
Tyagi was an Associate Professor at the University of Mississippi Medical Center before joining the University of Louisville in 2003. He earned his Ph.D. in biophysics at the University of Aligarh, India. He completed postgraduate work in bioinorganic chemistry at University College, Cork, Ireland and the State University of New York at Stony Brook, in Pharmacology and Pathology.